Johns Hopkins Medicine researchers report that a prospective study of 14 infants and children demonstrated that convalescent plasma—a blood product collected from patients recovered from infections ...

The results of a nationwide, multicenter clinical trial led by Johns Hopkins Medicine and the Johns Hopkins Bloomberg School of Public Health provide solid evidence for the use of plasma from ...

Convalescent plasma – a once-celebrated treatment for Covid-19 that has largely fallen out of favor – does work well for people who are immune-compromised, according to a study published Thursday. The ...

Research shows that high-titer (antibody-rich) COVID convalescent plasma -- when administered to COVID-19 outpatients within nine days after testing positive -- reduced the need for hospitalization ...

One dose of 200 mL of convalescent plasma (CP) derived from recently recovered donors with the neutralizing antibody titers above 1:640 was transfused to the patients as an addition to maximal ...

An Irvine couple who recovered from coronavirus is among the first in the Southland to donate to a study that researchers say is showing encouraging results as a potential coronavirus treatment.

Convalescent plasma treatment is being used at Children's Hospital Colorado. Doctors at Children's Hospital Colorado hoping to save lives amid a global pandemic are calling on people who have already ...

In a recent study posted to the medRxiv* preprint server, researchers conduct a quasi-experimental multi-center analytical study involving hospitalized coronavirus disease 2019 (COVID-19) patients to ...

High-titre convalescent plasma therapy given within a week of symptom onset reduced hospitalisation and death and was well tolerated in immunocompromised patients with mild COVID-19. This randomised ...

Andrew McLachlan receives research funding from the NHMRC and the Sydney Pharmacy School receives research scholarship funding from GSK for a PhD student under his supervision. Andrew has served as a ...